These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28219287)

  • 21. Ethical issues in stem cell research and therapy.
    King NM; Perrin J
    Stem Cell Res Ther; 2014 Jul; 5(4):85. PubMed ID: 25157428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research advances in induced pluripotent stem cells].
    Jiang XR; Lu SX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):456-61. PubMed ID: 21906458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stem cell research and science and technology policy in Japan].
    Yashiro Y
    Nihon Rinsho; 2011 Dec; 69(12):2251-6. PubMed ID: 22242329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induced pluripotent stem (iPS) cell research overview.
    Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From naïve pluripotency to chimeras: a new ethical challenge?
    Hyun I
    Development; 2015 Jan; 142(1):6-8. PubMed ID: 25516963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regeneration of the damaged central nervous system through reprogramming technology: basic concepts and potential application for cell replacement therapy.
    Matsui T; Akamatsu W; Nakamura M; Okano H
    Exp Neurol; 2014 Oct; 260():12-8. PubMed ID: 23036600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Death as the extinction of the source of value: the constructivist theory of death as an irreversible loss of moral status.
    Nowak PG
    Theor Med Bioeth; 2024 Apr; 45(2):109-131. PubMed ID: 38332427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced pluripotent stem cell-derived hepatocytes as an alternative to human adult hepatocytes.
    Katsuda T; Sakai Y; Ochiya T
    J Stem Cells; 2012; 7(1):1-17. PubMed ID: 23550341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human induced pluripotent stem cells: a review of the US patent landscape.
    Georgieva BP; Love JM
    Regen Med; 2010 Jul; 5(4):581-91. PubMed ID: 20632861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The moral value of induced pluripotent stem cells: a Japanese bioethics perspective on human embryo research.
    Sawai T
    J Med Ethics; 2014 Nov; 40(11):766-9. PubMed ID: 24951671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ethics of moral compromise for stem cell research policy.
    Master Z; Crozier GK
    Health Care Anal; 2012 Mar; 20(1):50-65. PubMed ID: 21484499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.
    Rowntree RK; McNeish JD
    Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A commentary on iPS cells: potential applications in autologous transplantation, study of illnesses and drug screening.
    Romano G; Morales F; Marino IR; Giordano A
    J Cell Physiol; 2014 Feb; 229(2):148-52. PubMed ID: 23881704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.
    Kumar D; Anand T; Kues WA
    Cell Biol Toxicol; 2017 Apr; 33(2):99-112. PubMed ID: 27900567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells.
    Rami F; Beni SN; Kahnamooi MM; Rahimmanesh I; Salehi AR; Salehi R
    Cell Reprogram; 2017 Apr; 19(2):65-74. PubMed ID: 28266864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced pluripotent stem cells: a new technology to study human diseases.
    Vitale AM; Wolvetang E; Mackay-Sim A
    Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced pluripotent stem cells: from derivation to application in biochemical and biomedical research.
    Novosadova EV; Grivennikov IA
    Biochemistry (Mosc); 2014 Dec; 79(13):1425-41. PubMed ID: 25749158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strange Bedfellows? Common Ground on the Moral Status Question.
    Wilkins SM
    J Med Philos; 2016 Apr; 41(2):130-47. PubMed ID: 26887642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.